Skip to content

Analysis of the symptom of gastro-esophageal reflux after H. pylori eradication

Analysis of the symptom of gastro-esophageal reflux after H. pylori eradication - Analysis of the symptom of gastro-esophageal reflux after H. pylori eradication

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000001399
Enrollment
200
Registered
2008-09-27
Start date
2008-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with H. pylori-positive peptic ulcer disease, who are planned to eradicate H. pylori.

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: H. pylori-positive patients with peptic ulver scar.

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity to omeprazole 2. patients taking atazanavir sulfate 3. Patients with severe liver dysfunction or renal dysfunction 4. Expectant mother 5. patients having taken PPIs 6. patients who is decided as not suitable to this study by doctors

Design outcomes

Primary

MeasureTime frame
Gastro-esophageal reflux score (QUEST), QOL score (QOLRAD-J) at 0, 1, 12, 24, 48 weeks after the H. pylori eradication

Secondary

MeasureTime frame
Pepsinogen I, pepsinogen II at 0, 3, 6 and 12 months after the H. pylori eradication

Countries

Japan

Contacts

Public ContactHidekazu Suzuki

Keio University School of Medicine Medical Education Center

hsuzuki.a6@keio.jp03-5363-3914

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026